Skip to main content
. 2024 Nov 6;13(22):6669. doi: 10.3390/jcm13226669

Table 3.

Clinical factors and medical treatment of patients.

Number
of Patients		 Percentage (%)
Male 35 55.6
Female 28 44.4
Smoking habit 11 17.5
Extra-intestinal manifestations: 12 9
Dermatological 2 3.2
Rheumatological 10 15.9
Perianal disease 4 6.3
Medical therapy:
  • -

    Anti-TNF a

 11 17.5
  • -

    Anti-IL23 b

 2 3.2
  • -

    Anti-integrin

 5 7.9
  • -

    Immunosuppressive drugs

 5 7.9
  • -

    Budesonide

 12 19.7
  • -

    Systemic corticosteroids

 2 3.2
  • -

    5-ASA c

 14 23

a Anti-tumor necrosis factor; b anti-interleukin 23; c 5-acetylsalicylic acid.